세계의 광견병 진단 시장 보고서(2025년)

Rabies diagnostics involve identifying the Rabies disease based on observed conditions and symptoms. This preventable viral illness is commonly transmitted through the bite of a rabid animal. Diagnosis of Rabies typically involves locating the rabies virus within any part of the infected animal's brain. In humans, diagnosis includes testing saliva, serum, spinal fluid, and skin biopsies from hair follicles at the back of the neck.

The methods employed in Rabies diagnostics encompass various tests such as fluorescent antibody tests, immunohistochemical tests, amplification methods, histologic examinations, and serology tests. The fluorescent antibody test (FA) is based on detecting rabies virus proteins (antigen) in the tissues of infected animals. Technologies utilized include ELISA/immunohistochemistry, chromatography techniques, PCR, and others. These diagnostics are commonly employed by hospitals, diagnostic centers, cancer palliative care clinics, and diverse end-users, including pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The rabies diagnostics market research report is one of a series of new reports from The Business Research Company that provides rabies diagnostics market statistics, including rabies diagnostics industry global market size, regional shares, competitors with a rabies diagnostics market share, detailed rabies diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the rabies diagnostics industry. This rabies diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rabies diagnostics market size has grown strongly in recent years. It will grow from $1.68 billion in 2024 to $1.78 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to globalization and travel patterns, one health approach adoption, regulatory standards development, advancements in animal testing, environmental influences.

The rabies diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.3 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing rabies incidence, environmental impact, cost efficiency, research and development, surveillance needs. Major trends in the forecast period include government initiatives and vaccination programs, globalization and travel, one health approach, public health concerns, remote and point-of-care diagnostics.

The forecast of 6.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Costlier imports of lab reagents and ELISA kits due to tariffs may delay testing efforts and strain rabies monitoring programs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of rabies is anticipated to drive the growth of the rabies diagnostics market. Rabies is a preventable viral disease primarily transmitted through the bite of an infected animal. The rabies virus affects the central nervous systems of mammals, ultimately leading to brain damage and death. Rabies diagnostics involve various tests and techniques to detect the presence of the rabies virus in both humans and animals. Furthermore, the increasing number of cases of infectious diseases transmitted by animals has heightened the demand for rabies diagnostics. For example, a report from the Government of Canada, published in January 2023, indicated that 135 rabies samples were submitted in October 2022, followed by 159 samples in November 2022. Consequently, the growing prevalence of rabies is expected to boost the rabies diagnostics market.

The ongoing trend of urbanization is anticipated to fuel the growth of the rabies diagnostics market. Urbanization, driven by economic growth and industrialization, transforms rural areas into urban hubs. In this transition, rabies diagnostics play a pivotal role in swiftly detecting and managing rabies outbreaks within densely populated urban settings, safeguarding public health. As per an April 2023 report by the World Bank Group, over half of the global population currently resides in urban areas, a figure projected to climb to 6 billion by 2045, marking a 1.5-fold increase. Consequently, the surging urbanization serves as a catalyst propelling the rabies diagnostics market forward.

The growing emphasis on research and development (R&D) activities is expected to boost the rabies diagnostics market. R&D encompasses the systematic investigation, experimentation, and innovation aimed at creating new products, enhancing existing ones, or developing new technologies and methodologies. The rise in R&D activities is attributed to various factors, including heightened awareness of diseases, increased public and private investments, and health initiatives. These activities contribute to advancements in rabies diagnostics by identifying novel biomarkers and testing methods that improve sensitivity and specificity. This progress facilitates the development of rapid, cost-effective tests for the timely detection of the virus in clinical samples. For instance, in December 2023, Eurostat, the statistical office of the European Union based in Luxembourg, reported that the EU's R&D expenditure reached €352 billion ($384.42 billion) in 2022, reflecting a 6.34% increase from €331 billion ($361.48 billion) the previous year. Thus, the escalation of research and development activities is likely to drive growth in the rabies diagnostics market.

Product innovation stands as a prominent trend shaping the rabies diagnostics market. Pharmaceutical manufacturers globally are focusing on developing sophisticated testing techniques within analytical chemistry to deliver precise and cost-effective analytical solutions. These testing products seamlessly integrate into routine sample testing processes. For instance, in May 2022, Bio-Rad Laboratories Inc., a US-based technology developer, unveiled the CFX Duet Real-Time PCR system. This clinical diagnostic device aids researchers in creating singleplex and duplex quantitative PCR (qPCR) tests, boasting enhanced thermal performance, a patented optical shuttle system, and thermal gradient functionality for optimization.

Leading companies in the rabies diagnostics market are focused on developing innovative products, such as rabies antibody test kits, to maintain their competitive edge. A rabies antibody test kit is a diagnostic tool that detects antibodies in the blood to evaluate immunity levels or determine the need for additional rabies vaccinations. For example, in February 2024, BioStone Animal Health, a US-based diagnostic company, introduced AsurDx. This rabies antibody test kit utilizes a rapid and sensitive ELISA method to identify antibodies specific to the rabies virus in mammalian serum samples. It offers a cost-effective solution for assessing rabies immunity, making it suitable for both vaccinated animals and those at risk. Designed for ease of use, the kit provides reliable results, helping ensure that animals meet the standard of 0.5 international units (UL) per ml for effective immune response against rabies.

Major companies operating in the rabies diagnostics market are Bio-Rad Laboratories Inc., The Merck Group, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics S.A., Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc., InBios International Inc., KHB Shanghai Kehua Bio-Engineering Co. Ltd., Meridian Bioscience Inc., MP Biomedicals LLC, Neogen Corporation, Randox Laboratories Ltd., SDIX LLC, Sigma-Aldrich Corporation, Virbac Animal health Pvt. Ltd., Zoetis Inc.

North America was the largest region in the rabies diagnostics market in 2024. The regions covered in the rabies diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rabies diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rabies diagnostics market includes revenues earned by entities by providing diagnostic services such as reverse transcription followed by polymerase chain reaction (RT-PCR), virus isolation, and direct fluorescent antibody (DFA) tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rabies Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rabies diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rabies diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rabies diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Diagnostic Method: Fluorescent Antibody Test; Immunohistochemical Test; Amplification Methods; Histologic Examination; Serology Tests
• 2) By Technology: ELISA Or Immunohistochemistry; Chromatography Techniques; PCR; Other Technologies
• 3) By End-User: Hospital; Diagnostic Centers; Cancer Palliative Care Clinics; Other End-Users
• Subsegments:
• 1) By Fluorescent Antibody Test: Direct Fluorescent Antibody Test (DFA)
• 2) By Immunohistochemical: Enzyme-Linked Immunosorbent Assay (ELISA): Western Blotting
• 3) By Amplification Methods: Polymerase Chain Reaction (PCR); Reverse Transcription PCR (RT-PCR)
• 4) By Histologic Examination: Microscopic Examination; Tissue Staining Techniques
• 5) By Serology Tests: Virus Neutralization Test (VNT); Enzyme-Linked Immunosorbent Assay (ELISA)
• Companies Mentioned: Bio-Rad Laboratories Inc.; The Merck Group; Aviva Systems Biology Corporation; Creative Diagnostics; Demeditec Diagnostics GmbH; Abbexa Ltd.; Norgen Biotek Corp.; BioNote Inc.; Express Biotech International Inc.; MyBioSource Inc.; QIAGEN N.V.; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Agilent Technologies Inc.; Fluidigm Corp.; Bio-X Diagnostics S.A.; Fujirebio Diagnostics Inc.; Gold Standard Diagnostics Corp.; Heska Corporation; IDEXX Laboratories Inc.; InBios International Inc.; KHB Shanghai Kehua Bio-Engineering Co. Ltd.; Meridian Bioscience Inc.; MP Biomedicals LLC; Neogen Corporation; Randox Laboratories Ltd.; SDIX LLC; Sigma-Aldrich Corporation; Virbac Animal health Pvt. Ltd.; Zoetis Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Rabies Diagnostics Market Characteristics

3. Rabies Diagnostics Market Trends And Strategies

4. Rabies Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Rabies Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Rabies Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Rabies Diagnostics Market Growth Rate Analysis
• 5.4. Global Rabies Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Rabies Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Rabies Diagnostics Total Addressable Market (TAM)

6. Rabies Diagnostics Market Segmentation

• 6.1. Global Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fluorescent Antibody Test
• Immunohistochemical Test
• Amplification Methods
• Histologic Examination
• Serology Tests
• 6.2. Global Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• ELISA Or Immunohistochemistry
• Chromatography Techniques
• PCR
• Other Technologies
• 6.3. Global Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Diagnostic Centres
• Cancer Palliative Care Clinics
• Other End-Users
• 6.4. Global Rabies Diagnostics Market, Sub-Segmentation Of Fluorescent Antibody Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Fluorescent Antibody Test (DFA)
• 6.5. Global Rabies Diagnostics Market, Sub-Segmentation Of Immunohistochemical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Linked Immunosorbent Assay (ELISA)
• Western Blotting
• 6.6. Global Rabies Diagnostics Market, Sub-Segmentation Of Amplification Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction (PCR)
• Reverse Transcription PCR (RT-PCR)
• 6.7. Global Rabies Diagnostics Market, Sub-Segmentation Of Histologic Examination, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microscopic Examination
• Tissue Staining Techniques
• 6.8. Global Rabies Diagnostics Market, Sub-Segmentation Of Serology Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Virus Neutralization Test (VNT)
• Enzyme-Linked Immunosorbent Assay (ELISA)

7. Rabies Diagnostics Market Regional And Country Analysis

• 7.1. Global Rabies Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Rabies Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Rabies Diagnostics Market

• 8.1. Asia-Pacific Rabies Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Rabies Diagnostics Market

• 9.1. China Rabies Diagnostics Market Overview
• 9.2. China Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Rabies Diagnostics Market

• 10.1. India Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Rabies Diagnostics Market

• 11.1. Japan Rabies Diagnostics Market Overview
• 11.2. Japan Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Rabies Diagnostics Market

• 12.1. Australia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Rabies Diagnostics Market

• 13.1. Indonesia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Rabies Diagnostics Market

• 14.1. South Korea Rabies Diagnostics Market Overview
• 14.2. South Korea Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Rabies Diagnostics Market

• 15.1. Western Europe Rabies Diagnostics Market Overview
• 15.2. Western Europe Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Rabies Diagnostics Market

• 16.1. UK Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Rabies Diagnostics Market

• 17.1. Germany Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Rabies Diagnostics Market

• 18.1. France Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Rabies Diagnostics Market

• 19.1. Italy Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Rabies Diagnostics Market

• 20.1. Spain Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Rabies Diagnostics Market

• 21.1. Eastern Europe Rabies Diagnostics Market Overview
• 21.2. Eastern Europe Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Rabies Diagnostics Market

• 22.1. Russia Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Rabies Diagnostics Market

• 23.1. North America Rabies Diagnostics Market Overview
• 23.2. North America Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Rabies Diagnostics Market

• 24.1. USA Rabies Diagnostics Market Overview
• 24.2. USA Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Rabies Diagnostics Market

• 25.1. Canada Rabies Diagnostics Market Overview
• 25.2. Canada Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Rabies Diagnostics Market

• 26.1. South America Rabies Diagnostics Market Overview
• 26.2. South America Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Rabies Diagnostics Market

• 27.1. Brazil Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Rabies Diagnostics Market

• 28.1. Middle East Rabies Diagnostics Market Overview
• 28.2. Middle East Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Rabies Diagnostics Market

• 29.1. Africa Rabies Diagnostics Market Overview
• 29.2. Africa Rabies Diagnostics Market, Segmentation By Diagnostic Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Rabies Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Rabies Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Rabies Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Rabies Diagnostics Market Competitive Landscape
• 30.2. Rabies Diagnostics Market Company Profiles
  • 30.2.1. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. The Merck Group Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Aviva Systems Biology Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Creative Diagnostics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Demeditec Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Rabies Diagnostics Market Other Major And Innovative Companies

• 31.1. Abbexa Ltd.
• 31.2. Norgen Biotek Corp.
• 31.3. BioNote Inc.
• 31.4. Express Biotech International Inc.
• 31.5. MyBioSource Inc.
• 31.6. QIAGEN N.V.
• 31.7. Thermo Fisher Scientific Inc.
• 31.8. F. Hoffmann-La Roche Ltd.
• 31.9. Agilent Technologies Inc.
• 31.10. Fluidigm Corp.
• 31.11. Bio-X Diagnostics S.A.
• 31.12. Fujirebio Diagnostics Inc.
• 31.13. Gold Standard Diagnostics Corp.
• 31.14. Heska Corporation
• 31.15. IDEXX Laboratories Inc.

32. Global Rabies Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rabies Diagnostics Market

34. Recent Developments In The Rabies Diagnostics Market

35. Rabies Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Rabies Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Rabies Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Rabies Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer